These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 2253317)

  • 1. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
    Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
    Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
    Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
    J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disparity between hypothermic coagulopathy and clotting studies.
    Reed RL; Johnson TD; Hudson JD; Fischer RP
    J Trauma; 1992 Sep; 33(3):465-70. PubMed ID: 1404519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clotting alterations in primary systemic amyloidosis.
    Gamba G; Montani N; Anesi E; Palladini G; Capezzera M; Soldavini E; Merlini G
    Haematologica; 2000 Mar; 85(3):289-92. PubMed ID: 10702818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical data obtained through coagulation testing suggests that hypothermia exerts influence on a patient's blood coagulation reaction].
    Fukuda A; Ishida H; Kubota M; Kojima Y; Mizobata Y; Matsuoka T; Yokota J
    Rinsho Byori; 2000 Dec; 48(12):1102-8. PubMed ID: 11215418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
    Dirkmann D; Hanke AA; Görlinger K; Peters J
    Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
    Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigation of coagulation by removing clotting factors part 1: in vitro feasibility study.
    Parker JT; Beutler DS; Sukavaneshvar S; Jacobs N; Solen KA; Mohammad SF
    ASAIO J; 2007; 53(4):415-20. PubMed ID: 17667224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
    Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs.
    Moreno P; Ginel PJ
    Res Vet Sci; 1999 Dec; 67(3):273-6. PubMed ID: 10607508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of clotting screens.
    Thorell SE; Nash MJ; Thachil J
    Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasciola hepatica alters coagulation parameters in sheep plasma in vivo and in vitro.
    Joachim A; Ali SF; Daugschies A
    Parasitol Res; 2003 Jan; 89(1):53-8. PubMed ID: 12474044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.